Element Wealth, LLC

Q1 2022 13F Holdings Report, Stock Holdings

Signature - Title
Barry Smith - Chief Compliance Officer
Location
Ridgeland, MS
Holdings as of
31 Mar 2022
Value $
$123,700,000
Num holdings
204
Filing time
28 Apr 2022, 15:56:42 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included IVV, DIVO, SCHX, SPY, and IJR.
Previous filing
Q4 2021 - 03 Feb 2022
Next filing
Q2 2022 - 22 Jul 2022
Options Holdings
Showing stock holdings, see here for options holdings

Quoteable Key Fact

"Element Wealth, LLC reported $123,700,000 across 204 holdings in Q1 2022."

Quick Takeaways

  • Element Wealth, LLC reported 13f holdings report, stock holdings for Q1 2022.
  • Reported holdings value: $123,700,000.
  • 204 holdings are listed in this filing snapshot.

What Changed

  • Previous comparable filing: Q4 2021.
  • Value moved from $132,045,000 to $123,700,000.

Why This Matters

  • This filing-level page explains what the portfolio report tells you before the holdings table.
  • You can cite quarter, value, and filing timestamp directly from SEC-linked data.

Source Evidence

Backed by Form 13F

Portfolio-level numbers on this page come from the original SEC Form 13F filing.

See Original Filing
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2022 Q1 compared to 2021 Q4 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Barry Smith Chief Compliance Officer Ridgeland, Mississippi 28 Apr 2022
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .